{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T12:26:59Z","timestamp":1784204819056,"version":"3.55.0"},"reference-count":65,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,9,2]],"date-time":"2024-09-02T00:00:00Z","timestamp":1725235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,9,2]],"date-time":"2024-09-02T00:00:00Z","timestamp":1725235200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["World J Surg Onc"],"DOI":"10.1186\/s12957-024-03516-0","type":"journal-article","created":{"date-parts":[[2024,9,2]],"date-time":"2024-09-02T03:16:18Z","timestamp":1725246978000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Impact of imaging-diagnosed sarcopenia on outcomes in patients with biliary tract cancer after surgical resection: a systematic review and meta-analysis"],"prefix":"10.1186","volume":"22","author":[{"given":"Jun","family":"Ji","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shizheng","family":"Mi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziqi","family":"Hou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhihong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guoteng","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhaoxing","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiwei","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,9,2]]},"reference":[{"issue":"10272","key":"3516_CR1","first-page":"428","volume":"397","author":"JW Valle","year":"2021","unstructured":"Valle JW, Kelley RK, Nervi B, et al. Biliary tract cancer. Lancet. 2021;397(10272):428\u201344.","journal-title":"Biliary Tract cancer Lancet"},{"issue":"2","key":"3516_CR2","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.annonc.2022.10.506","volume":"34","author":"A Vogel","year":"2023","unstructured":"Vogel A, Bridgewater J, Edeline J, et al. Biliary tract cancer: ESMO clinical practice guideline for diagnosis, treatment and follow-up. Annals Oncology: Official J Eur Soc Med Oncol. 2023;34(2):127\u201340.","journal-title":"Annals Oncology: Official J Eur Soc Med Oncol"},{"issue":"9","key":"3516_CR3","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1038\/s41575-020-0310-z","volume":"17","author":"JM Banales","year":"2020","unstructured":"Banales JM, Marin JJG, Lamarca A, et al. Cholangiocarcinoma 2020: the next horizon in mechanisms and management. Nat Rev Gastroenterol Hepatol. 2020;17(9):557\u201388.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"1","key":"3516_CR4","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1093\/ageing\/afy169","volume":"48","author":"AJ Cruz-Jentoft","year":"2019","unstructured":"Cruz-Jentoft AJ, Bahat G, Bauer J, et al. Sarcopenia: revised European consensus on definition and diagnosis. Age Ageing. 2019;48(1):16\u201331.","journal-title":"Age Ageing"},{"issue":"21","key":"3516_CR5","doi-asserted-by":"publisher","first-page":"7964","DOI":"10.1002\/cam4.3428","volume":"9","author":"L Xia","year":"2020","unstructured":"Xia L, Zhao R, Wan Q, et al. Sarcopenia and adverse health-related outcomes: an umbrella review of meta-analyses of observational studies. Cancer Med. 2020;9(21):7964\u201378.","journal-title":"Cancer Med"},{"issue":"8","key":"3516_CR6","doi-asserted-by":"publisher","first-page":"1761","DOI":"10.1002\/jpen.2415","volume":"46","author":"A Surov","year":"2022","unstructured":"Surov A, Wienke A. Prevalence of sarcopenia in patients with solid tumors: a meta-analysis based on 81,814 patients. JPEN J Parenter Enter Nutr. 2022;46(8):1761\u20138.","journal-title":"JPEN J Parenter Enter Nutr"},{"key":"3516_CR7","doi-asserted-by":"crossref","unstructured":"Rosenberg IHJTAJoCN. Summary comments: epidemiological and methodological problem in determining nutritional status of older persons. 1989;50:1231\u20133.","DOI":"10.1093\/ajcn\/50.5.1231"},{"issue":"5 Suppl","key":"3516_CR8","doi-asserted-by":"publisher","first-page":"S990","DOI":"10.1093\/jn\/127.5.990S","volume":"127","author":"IH Rosenberg","year":"1997","unstructured":"Rosenberg IH. Sarcopenia: origins and clinical relevance. J Nutr. 1997;127(5 Suppl):S990\u20131.","journal-title":"J Nutr"},{"issue":"5","key":"3516_CR9","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1002\/jcsm.12147","volume":"7","author":"SD Anker","year":"2016","unstructured":"Anker SD, Morley JE, von Haehling S. Welcome to the ICd-10 code for sarcopenia. J Cachexia Sarcopenia Muscle. 2016;7(5):512\u20134.","journal-title":"J Cachexia Sarcopenia Muscle"},{"issue":"1","key":"3516_CR10","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.clnu.2016.09.004","volume":"36","author":"T Cederholm","year":"2017","unstructured":"Cederholm T, Barazzoni R, Austin P, et al. ESPEN guidelines on definitions and terminology of clinical nutrition. Clin Nutr. 2017;36(1):49\u201364.","journal-title":"Clin Nutr"},{"issue":"2","key":"3516_CR11","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.jamda.2013.11.025","volume":"15","author":"L-K Chen","year":"2014","unstructured":"Chen L-K, Liu L-K, Woo J, et al. Sarcopenia in Asia: consensus report of the Asian working group for sarcopenia. J Am Med Dir Assoc. 2014;15(2):95\u2013101.","journal-title":"J Am Med Dir Assoc"},{"issue":"12","key":"3516_CR12","doi-asserted-by":"publisher","first-page":"1448","DOI":"10.1002\/bjs.9893","volume":"102","author":"S Levolger","year":"2015","unstructured":"Levolger S, van Vugt JL, de Bruin RW, JN IJ. Systematic review of sarcopenia in patients operated on for gastrointestinal and hepatopancreatobiliary malignancies. Br J Surg. 2015;102(12):1448\u201358.","journal-title":"Br J Surg"},{"issue":"2","key":"3516_CR13","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1016\/j.clnu.2021.12.005","volume":"41","author":"J Watanabe","year":"2022","unstructured":"Watanabe J, Matsui R, Sasanuma H, et al. Body composition assessment and sarcopenia in patients with biliary tract cancer: a systematic review and meta-analysis. Clin Nutr. 2022;41(2):321\u20138.","journal-title":"Clin Nutr"},{"issue":"7","key":"3516_CR14","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1016\/j.hpb.2021.11.012","volume":"24","author":"A Surov","year":"2022","unstructured":"Surov A, Pech M, Omari J, et al. Low skeletal muscle mass in cholangiocarcinoma treated by surgical resection. A meta-analysis. HPB: Official J Int Hepato Pancreato Biliary Association. 2022;24(7):997\u20131006.","journal-title":"HPB: Official J Int Hepato Pancreato Biliary Association"},{"key":"3516_CR15","doi-asserted-by":"crossref","unstructured":"Shin SP, Koh DH. Clinical impact of sarcopenia on cholangiocarcinoma. Life (Basel Switzerland). 2022;12(6).","DOI":"10.3390\/life12060815"},{"issue":"3","key":"3516_CR16","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1002\/ags3.12644","volume":"7","author":"K Hayashi","year":"2023","unstructured":"Hayashi K, Abe Y, Kitago M, et al. Prognostic impact of preoperative skeletal muscle change from diagnosis to surgery in patients with perihilar cholangiocarcinoma. Ann Gastroenterol Surg. 2023;7(3):523\u201332.","journal-title":"Ann Gastroenterol Surg"},{"key":"3516_CR17","doi-asserted-by":"publisher","first-page":"24","DOI":"10.3390\/jcm12247747","volume":"12","author":"G Wang","year":"2023","unstructured":"Wang G, Otto CC, Heij LR, et al. Impact of altered body composition on clinical and oncological outcomes in intrahepatic cholangiocarcinoma. J Clin Med. 2023;12:24.","journal-title":"J Clin Med"},{"key":"3516_CR18","doi-asserted-by":"crossref","unstructured":"Utsumi M, Inagaki M, Kitada K et al. Prognostic significance of Sarcopenia and systemic inflammatory markers in biliary tract cancer: a retrospective cohort study. J Gastrointest Cancer. 2024.","DOI":"10.21203\/rs.3.rs-3676281\/v1"},{"issue":"1","key":"3516_CR19","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1111\/liv.15757","volume":"44","author":"Z Zhao","year":"2024","unstructured":"Zhao Z, Bo Z, Ye N, et al. Impact of Sarcopenia on postoperative outcomes after hepatectomy in older patients with intrahepatic cholangiocarcinoma: a multicentre cohort study. Liver Int. 2024;44(1):155\u201368.","journal-title":"Liver Int"},{"key":"3516_CR20","doi-asserted-by":"publisher","first-page":"n71","DOI":"10.1136\/bmj.n71","volume":"372","author":"MJ Page","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372:n71.","journal-title":"BMJ"},{"issue":"2","key":"3516_CR21","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1097\/SLA.0b013e3181b13ca2","volume":"250","author":"PA Clavien","year":"2009","unstructured":"Clavien PA, Barkun J, de Oliveira ML, et al. The Clavien-Dindo classification of surgical complications: five-year experience. Ann Surg. 2009;250(2):187\u201396.","journal-title":"Ann Surg"},{"key":"3516_CR22","unstructured":"Wells GA, Wells G, Shea B et al. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. 2014."},{"issue":"1","key":"3516_CR23","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1186\/1472-6963-4-38","volume":"4","author":"D Atkins","year":"2004","unstructured":"Atkins D, Eccles M, Flottorp S, et al. Systems for grading the quality of evidence and the strength of recommendations I: critical appraisal of existing approaches the GRADE working group. BMC Health Serv Res. 2004;4(1):38.","journal-title":"BMC Health Serv Res"},{"issue":"7414","key":"3516_CR24","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","volume":"327","author":"JP Higgins","year":"2003","unstructured":"Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ. 2003;327(7414):557\u201360.","journal-title":"BMJ"},{"issue":"7109","key":"3516_CR25","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","volume":"315","author":"M Egger","year":"1997","unstructured":"Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997;315(7109):629\u201334.","journal-title":"BMJ"},{"issue":"6","key":"3516_CR26","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1111\/hpb.12394","volume":"17","author":"RJ Coelen","year":"2015","unstructured":"Coelen RJ, Wiggers JK, Nio CY, et al. Preoperative computed tomography assessment of skeletal muscle mass is valuable in predicting outcomes following hepatectomy for perihilar cholangiocarcinoma. HPB: Official J Int Hepato Pancreato Biliary Association. 2015;17(6):520\u20138.","journal-title":"HPB: Official J Int Hepato Pancreato Biliary Association"},{"issue":"10","key":"3516_CR27","first-page":"18245","volume":"8","author":"G Zhou","year":"2015","unstructured":"Zhou G, Bao H, Zeng Q, et al. Sarcopenia as a prognostic factor in hepatolithiasis-associated intrahepatic cholangiocarcinoma patients following hepatectomy: a retrospective study. Int J Clin Exp Med. 2015;8(10):18245\u201354.","journal-title":"Int J Clin Exp Med"},{"issue":"3","key":"3516_CR28","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1016\/j.surg.2015.08.047","volume":"159","author":"S Okumura","year":"2016","unstructured":"Okumura S, Kaido T, Hamaguchi Y, et al. Impact of the preoperative quantity and quality of skeletal muscle on outcomes after resection of extrahepatic biliary malignancies. Surgery. 2016;159(3):821\u201333.","journal-title":"Surgery"},{"issue":"4","key":"3516_CR29","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1245\/s10434-016-5668-3","volume":"24","author":"S Okumura","year":"2017","unstructured":"Okumura S, Kaido T, Hamaguchi Y, et al. Impact of skeletal muscle mass, muscle quality, and visceral adiposity on outcomes following resection of intrahepatic cholangiocarcinoma. Ann Surg Oncol. 2017;24(4):1037\u201345.","journal-title":"Ann Surg Oncol"},{"issue":"10","key":"3516_CR30","doi-asserted-by":"publisher","first-page":"1697","DOI":"10.1007\/s11605-018-3802-1","volume":"22","author":"J Chakedis","year":"2018","unstructured":"Chakedis J, Spolverato G, Beal EW, et al. Pre-operative sarcopenia identifies patients at risk for poor survival after resection of biliary tract cancers. J Gastrointest Surgery: Official J Soc Surg Aliment Tract. 2018;22(10):1697\u2013708.","journal-title":"J Gastrointest Surgery: Official J Soc Surg Aliment Tract"},{"issue":"9","key":"3516_CR31","doi-asserted-by":"publisher","first-page":"E654","DOI":"10.1111\/ans.14304","volume":"88","author":"S Umetsu","year":"2018","unstructured":"Umetsu S, Wakiya T, Ishido K, et al. Effect of sarcopenia on the outcomes after pancreaticoduodenectomy for distal cholangiocarcinoma. ANZ J Surg. 2018;88(9):E654\u20138.","journal-title":"ANZ J Surg"},{"issue":"7","key":"3516_CR32","doi-asserted-by":"publisher","first-page":"1307","DOI":"10.1111\/liv.14132","volume":"39","author":"F Hahn","year":"2019","unstructured":"Hahn F, Muller L, Stohr F, et al. The role of sarcopenia in patients with intrahepatic cholangiocarcinoma: prognostic marker or hyped parameter? Liver Int. 2019;39(7):1307\u201314.","journal-title":"Liver Int"},{"issue":"4","key":"3516_CR33","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1002\/jcsm.12431","volume":"10","author":"SB Yoon","year":"2019","unstructured":"Yoon SB, Choi MH, Song M, et al. Impact of preoperative body compositions on survival following resection of biliary tract cancer. J Cachexia Sarcopenia Muscle. 2019;10(4):794\u2013802.","journal-title":"J Cachexia Sarcopenia Muscle"},{"issue":"5","key":"3516_CR34","doi-asserted-by":"publisher","first-page":"952","DOI":"10.1016\/j.amjsurg.2019.03.010","volume":"218","author":"K Yugawa","year":"2019","unstructured":"Yugawa K, Itoh S, Kurihara T, et al. Skeletal muscle mass predicts the prognosis of patients with intrahepatic cholangiocarcinoma. Am J Surg. 2019;218(5):952\u20138.","journal-title":"Am J Surg"},{"issue":"5","key":"3516_CR35","doi-asserted-by":"publisher","first-page":"1082","DOI":"10.1007\/s11605-019-04198-w","volume":"24","author":"EC Lee","year":"2020","unstructured":"Lee EC, Park SJ, Lee SD, et al. Effects of sarcopenia on prognosis after resection of gallbladder cancer. J Gastrointest Surgery: Official J Soc Surg Aliment Tract. 2020;24(5):1082\u201391.","journal-title":"J Gastrointest Surgery: Official J Soc Surg Aliment Tract"},{"key":"3516_CR36","doi-asserted-by":"crossref","unstructured":"Deng L, Wang Y, Zhao J et al. The prognostic value of sarcopenia combined with hepatolithiasis in intrahepatic cholangiocarcinoma patients after surgery: a prospective cohort study. Eur J Surg Oncology: J Eur Soc Surg Oncol Br Association Surg Oncol. 2021;47(3 Pt B):603\u201312.","DOI":"10.1016\/j.ejso.2020.09.002"},{"key":"3516_CR37","doi-asserted-by":"publisher","first-page":"21","DOI":"10.3390\/cancers13215359","volume":"13","author":"MS Jordens","year":"2021","unstructured":"Jordens MS, Heinrichs L, Loosen SH, et al. Sarcopenia predicts cancer mortality in male but not in female patients undergoing surgery for cholangiocellular carcinoma. Cancers (Basel). 2021;13:21.","journal-title":"Cancers (Basel)"},{"issue":"6","key":"3516_CR38","doi-asserted-by":"publisher","first-page":"3891","DOI":"10.1016\/j.clnu.2021.04.038","volume":"40","author":"H Li","year":"2021","unstructured":"Li H, Dai J, Lan T, et al. Combination of albumin-globulin score and skeletal muscle index predicts long-term outcomes of intrahepatic cholangiocarcinoma patients after curative resection. Clin Nutr. 2021;40(6):3891\u2013900.","journal-title":"Clin Nutr"},{"issue":"5","key":"3516_CR39","doi-asserted-by":"publisher","first-page":"3552","DOI":"10.1016\/j.clnu.2020.12.011","volume":"40","author":"S Tamura","year":"2021","unstructured":"Tamura S, Ashida R, Sugiura T, et al. The prognostic impact of skeletal muscle status and bone mineral density for resected distal cholangiocarcinoma. Clin Nutr. 2021;40(5):3552\u20138.","journal-title":"Clin Nutr"},{"key":"3516_CR40","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.clnesp.2022.10.003","volume":"52","author":"R Ashida","year":"2022","unstructured":"Ashida R, Yamamoto Y, Aramaki T, et al. Preoperative skeletal muscle fat infiltration is a strong predictor of poorer survival in gallbladder cancer underwent surgery. Clin Nutr ESPEN. 2022;52:60\u20137.","journal-title":"Clin Nutr ESPEN"},{"issue":"1","key":"3516_CR41","doi-asserted-by":"publisher","first-page":"1358","DOI":"10.1186\/s12885-022-10453-2","volume":"22","author":"S Yasuta","year":"2022","unstructured":"Yasuta S, Sugimoto M, Kudo M, et al. Early postoperative decrease of skeletal muscle mass predicts recurrence and poor survival after surgical resection for perihilar cholangiocarcinoma. BMC Cancer. 2022;22(1):1358.","journal-title":"BMC Cancer"},{"issue":"2","key":"3516_CR42","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1002\/jhbp.1220","volume":"30","author":"Y Asai","year":"2023","unstructured":"Asai Y, Yamaguchi J, Mizuno T, et al. Impact of preoperative muscle mass and quality on surgical outcomes in patients undergoing major hepatectomy for perihilar cholangiocarcinoma. J Hepato-Biliary-Pancreat Sci. 2023;30(2):202\u201311.","journal-title":"J Hepato-Biliary-Pancreat Sci"},{"issue":"2","key":"3516_CR43","doi-asserted-by":"publisher","first-page":"879","DOI":"10.21873\/invivo.13156","volume":"37","author":"S Ikuta","year":"2023","unstructured":"Ikuta S, Aihara T, Nakajima T, et al. Preoperative psoas muscle thickness to height ratio predicts poor survival after resection of biliary tract cancer. Vivo. 2023;37(2):879\u201386.","journal-title":"Vivo"},{"key":"3516_CR44","doi-asserted-by":"publisher","first-page":"1136376","DOI":"10.3389\/fonc.2023.1136376","volume":"13","author":"HE Jung","year":"2023","unstructured":"Jung HE, Han DH, Koo BN, Kim J. Effect of Sarcopenia on postoperative ICU admission and length of stay after hepatic resection for Klatskin tumor. Front Oncol. 2023;13:1136376.","journal-title":"Front Oncol"},{"issue":"1","key":"3516_CR45","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1080\/01635581.2022.2117387","volume":"75","author":"L Lacaze","year":"2023","unstructured":"Lacaze L, Bergeat D, Rousseau C, et al. High visceral fat is associated with a worse survival after liver resection for intrahepatic cholangiocarcinoma. Nutr Cancer. 2023;75(1):339\u201348.","journal-title":"Nutr Cancer"},{"issue":"1","key":"3516_CR46","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1007\/s00595-022-02550-3","volume":"53","author":"T Taniai","year":"2023","unstructured":"Taniai T, Haruki K, Yanagaki M, et al. Osteosarcopenia predicts poor prognosis for patients with intrahepatic cholangiocarcinoma after hepatic resection. Surg Today. 2023;53(1):82\u20139.","journal-title":"Surg Today"},{"key":"3516_CR47","doi-asserted-by":"crossref","unstructured":"Wang G, Mantas A, Heij LR et al. Body composition is associated with postoperative complications in perihilar cholangiocarcinoma. Cancer Med. 2024;13(1).","DOI":"10.1002\/cam4.6878"},{"issue":"7","key":"3516_CR48","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1016\/S1470-2045(08)70153-0","volume":"9","author":"CM Prado","year":"2008","unstructured":"Prado CM, Lieffers JR, McCargar LJ, et al. Prevalence and clinical implications of sarcopenic obesity in patients with solid tumours of the respiratory and gastrointestinal tracts: a population-based study. Lancet Oncol. 2008;9(7):629\u201335.","journal-title":"Lancet Oncol"},{"issue":"5","key":"3516_CR49","doi-asserted-by":"publisher","first-page":"e0127538","DOI":"10.1371\/journal.pone.0127538","volume":"10","author":"SJ Li","year":"2015","unstructured":"Li SJ, Jiang H, Yang H, et al. The dilemma of heterogeneity tests in meta-analysis: a challenge from a simulation study. PLoS ONE. 2015;10(5):e0127538.","journal-title":"PLoS ONE"},{"issue":"1","key":"3516_CR50","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1093\/ije\/31.1.107","volume":"31","author":"CL Vale","year":"2002","unstructured":"Vale CL, Tierney JF, Stewart LA. Effects of adjusting for censoring on meta-analyses of time-to-event outcomes. Int J Epidemiol. 2002;31(1):107\u201311.","journal-title":"Int J Epidemiol"},{"issue":"1","key":"3516_CR51","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1186\/2049-3258-72-45","volume":"72","author":"C Beaudart","year":"2014","unstructured":"Beaudart C, Rizzoli R, Bruyere O, et al. Sarcopenia: burden and challenges for public health. Arch Public Health. 2014;72(1):45.","journal-title":"Arch Public Health"},{"key":"3516_CR52","doi-asserted-by":"publisher","first-page":"15","DOI":"10.3390\/cells11152359","volume":"11","author":"GE Jimenez-Gutierrez","year":"2022","unstructured":"Jimenez-Gutierrez GE, Martinez-Gomez LE, Martinez-Armenta C, et al. Molecular mechanisms of inflammation in sarcopenia: diagnosis and therapeutic update. Cells. 2022;11:15.","journal-title":"Cells"},{"issue":"1","key":"3516_CR53","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.clnu.2011.07.010","volume":"31","author":"C Scheede-Bergdahl","year":"2012","unstructured":"Scheede-Bergdahl C, Watt HL, Trutschnigg B, et al. Is IL-6 the best pro-inflammatory biomarker of clinical outcomes of cancer cachexia? Clin Nutr. 2012;31(1):85\u20138.","journal-title":"Clin Nutr"},{"issue":"4","key":"3516_CR54","doi-asserted-by":"publisher","first-page":"1613","DOI":"10.1002\/jcsm.13230","volume":"14","author":"F Pigneur","year":"2023","unstructured":"Pigneur F, Di Palma M, Raynard B, et al. Psoas muscle index is not representative of skeletal muscle index for evaluating cancer sarcopenia. J Cachexia Sarcopenia Muscle. 2023;14(4):1613\u201320.","journal-title":"J Cachexia Sarcopenia Muscle"},{"issue":"2","key":"3516_CR55","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1093\/oxfordjournals.bmb.a072256","volume":"44","author":"HJ Burns","year":"1988","unstructured":"Burns HJ. Nutritional support in the perioperative period. Br Med Bull. 1988;44(2):357\u201373.","journal-title":"Br Med Bull"},{"issue":"1","key":"3516_CR56","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1038\/s41467-020-20123-1","volume":"12","author":"R Sartori","year":"2021","unstructured":"Sartori R, Romanello V, Sandri M. Mechanisms of muscle atrophy and hypertrophy: implications in health and disease. Nat Commun. 2021;12(1):330.","journal-title":"Nat Commun"},{"issue":"2","key":"3516_CR57","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1159\/000504604","volume":"9","author":"H Uojima","year":"2020","unstructured":"Uojima H, Chuma M, Tanaka Y, et al. Skeletal muscle mass influences tolerability and prognosis in hepatocellular carcinoma patients treated with lenvatinib. Liver Cancer. 2020;9(2):193\u2013206.","journal-title":"Liver Cancer"},{"key":"3516_CR58","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.coph.2015.04.003","volume":"22","author":"JM Argiles","year":"2015","unstructured":"Argiles JM, Busquets S, Stemmler B, Lopez-Soriano FJ. Cachexia and sarcopenia: mechanisms and potential targets for intervention. Curr Opin Pharmacol. 2015;22:100\u20136.","journal-title":"Curr Opin Pharmacol"},{"issue":"12","key":"3516_CR59","doi-asserted-by":"publisher","first-page":"e172319","DOI":"10.1001\/jamaoncol.2017.2319","volume":"3","author":"EMC Feliciano","year":"2017","unstructured":"Feliciano EMC, Kroenke CH, Meyerhardt JA, et al. Association of systemic inflammation and sarcopenia with survival in nonmetastatic colorectal cancer: results from the C SCANS study. JAMA Oncol. 2017;3(12):e172319.","journal-title":"JAMA Oncol"},{"issue":"6","key":"3516_CR60","doi-asserted-by":"publisher","first-page":"486","DOI":"10.2174\/1389201017666160301102713","volume":"17","author":"D Liu","year":"2016","unstructured":"Liu D, Wang X, Chen Z. Tumor necrosis factor-alpha, a regulator and therapeutic agent on breast cancer. Curr Pharm Biotechnol. 2016;17(6):486\u201394.","journal-title":"Curr Pharm Biotechnol"},{"key":"3516_CR61","doi-asserted-by":"publisher","first-page":"101530","DOI":"10.1016\/j.arr.2021.101530","volume":"73","author":"A Picca","year":"2022","unstructured":"Picca A, Coelho-Junior HJ, Calvani R, et al. Biomarkers shared by frailty and sarcopenia in older adults: a systematic review and meta-analysis. Ageing Res Rev. 2022;73:101530.","journal-title":"Ageing Res Rev"},{"issue":"4","key":"3516_CR62","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1007\/s10120-016-0668-3","volume":"20","author":"D Kobayashi","year":"2017","unstructured":"Kobayashi D, Ishigure K, Mochizuki Y, et al. Multi-institutional prospective feasibility study to explore tolerability and efficacy of oral nutritional supplements for patients with gastric cancer undergoing gastrectomy (CCOG1301). Gastric Cancer. 2017;20(4):718\u201327.","journal-title":"Gastric Cancer"},{"issue":"1","key":"3516_CR63","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1245\/s10434-018-6943-2","volume":"26","author":"H Nakajima","year":"2019","unstructured":"Nakajima H, Yokoyama Y, Inoue T, et al. Clinical benefit of preoperative exercise and nutritional therapy for patients undergoing hepato-pancreato-biliary surgeries for malignancy. Ann Surg Oncol. 2019;26(1):264\u201372.","journal-title":"Ann Surg Oncol"},{"key":"3516_CR64","doi-asserted-by":"crossref","unstructured":"Muscaritoli M, Bar-Sela G, Battisti NML et al. Oncology-led early identification of nutritional risk: a pragmatic, evidence-based protocol (PRONTO). Cancers (Basel). 2023;15(2).","DOI":"10.3390\/cancers15020380"},{"issue":"5","key":"3516_CR65","doi-asserted-by":"publisher","first-page":"714","DOI":"10.3348\/kjr.2020.0689","volume":"22","author":"J Yoo","year":"2021","unstructured":"Yoo J, Lee JM, Yoon JH, et al. Additional value of integrated (18)F-FDG PET\/MRI for evaluating biliary tract cancer: comparison with contrast-enhanced CT. Korean J Radiol. 2021;22(5):714\u201324.","journal-title":"Korean J Radiol"}],"container-title":["World Journal of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12957-024-03516-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12957-024-03516-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12957-024-03516-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,2]],"date-time":"2024-09-02T15:05:44Z","timestamp":1725289544000},"score":1,"resource":{"primary":{"URL":"https:\/\/wjso.biomedcentral.com\/articles\/10.1186\/s12957-024-03516-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,2]]},"references-count":65,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["3516"],"URL":"https:\/\/doi.org\/10.1186\/s12957-024-03516-0","relation":{},"ISSN":["1477-7819"],"issn-type":[{"value":"1477-7819","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,2]]},"assertion":[{"value":"4 May 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 August 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 September 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to publish"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"229"}}